HCA Healthcare, Inc. $HCA Shares Purchased by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 68,638 shares of the company’s stock after buying an additional 1,500 shares during the period. KLP Kapitalforvaltning AS’s holdings in HCA Healthcare were worth $29,254,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Chung Wu Investment Group LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter worth about $27,000. Clearstead Trust LLC raised its holdings in HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after buying an additional 53 shares during the period. Ameriflex Group Inc. purchased a new stake in HCA Healthcare during the second quarter worth approximately $27,000. Harbor Capital Advisors Inc. raised its stake in shares of HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after acquiring an additional 34 shares during the period. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in HCA Healthcare in the 2nd quarter valued at $40,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $470.23 on Thursday. HCA Healthcare, Inc. has a 1-year low of $295.00 and a 1-year high of $520.00. The company’s fifty day moving average is $479.37 and its two-hundred day moving average is $426.03. The stock has a market capitalization of $107.30 billion, a price-to-earnings ratio of 18.18, a price-to-earnings-growth ratio of 1.33 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same period in the prior year, the company earned $4.90 earnings per share. The business’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were given a dividend of $0.72 per share. The ex-dividend date was Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Analysts Set New Price Targets

HCA has been the subject of several analyst reports. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Zacks Research lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Truist Financial upped their price objective on shares of HCA Healthcare from $495.00 to $520.00 and gave the company a “buy” rating in a research report on Monday. Robert W. Baird lifted their target price on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Finally, Wells Fargo & Company raised their price objective on HCA Healthcare from $431.00 to $452.00 and gave the company an “equal weight” rating in a research note on Wednesday. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $485.95.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.